A Phase 1b Study to Evaluate the Safety and Efficacy of Durvalumab in Combination With Tremelimumab or Danvatirsen in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Ribrag, Vincent ; Lee, Seung Tae ; Rizzieri, David ; Dyer, Martin J.S. ; Fayad, Luis ; Kurzrock, Razelle ; Andritsos, Leslie ; Bouabdallah, Reda ; Hayat, Amjad ; Bacon, Larry ; Jiang, Yu ; Miah, Kowser ; Delafont, Bruno ; Hamid, Oday ; Anyanwu, Stephanie ; Martinez, Pablo ; Hess, Brian
Clinical lymphoma, myeloma and leukemia, 2021-05, Vol.21 (5), p.309-317.e3 [Periódico revisado por pares]United States: Elsevier Inc
Texto completo disponível